These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 1446923

  • 1. Tetrapeptide QDPR is a minimal immunodominant epitope within the preS2 domain of hepatitis B virus.
    Sominskaya I, Bichko V, Pushko P, Dreimane A, Snikere D, Pumpens P.
    Immunol Lett; 1992 Jul; 33(2):169-72. PubMed ID: 1446923
    [Abstract] [Full Text] [Related]

  • 2. Fine mapping and functional characterization of two immuno-dominant regions from the preS2 sequence of hepatitis B virus.
    Meisel H, Sominskaya I, Pumpens P, Pushko P, Borisova G, Deepen R, Lu X, Spiller GH, Krüger DH, Grens E.
    Intervirology; 1994 Jul; 37(6):330-9. PubMed ID: 8586531
    [Abstract] [Full Text] [Related]

  • 3. Mapping of immunodominant B-cell epitopes and the human serum albumin-binding site in natural hepatitis B virus surface antigen of defined genosubtype.
    Sobotta D, Sominskaya I, Jansons J, Meisel H, Schmitt S, Heermann KH, Kaluza G, Pumpens P, Gerlich WH.
    J Gen Virol; 2000 Feb; 81(Pt 2):369-78. PubMed ID: 10644835
    [Abstract] [Full Text] [Related]

  • 4. Determination of the minimal length of preS1 epitope recognized by a monoclonal antibody which inhibits attachment of hepatitis B virus to hepatocytes.
    Sominskaya I, Pushko P, Dreilina D, Kozlovskaya T, Pumpen P.
    Med Microbiol Immunol; 1992 Feb; 181(4):215-26. PubMed ID: 1279369
    [Abstract] [Full Text] [Related]

  • 5. Discrimination of hepatitis B virus (HBV) subtypes using monoclonal antibodies to the PreS1 and PreS2 domains of the viral envelope.
    Mimms LT, Floreani M, Tyner J, Whitters E, Rosenlof R, Wray L, Goetze A, Sarin V, Eble K.
    Virology; 1990 Jun; 176(2):604-19. PubMed ID: 1693248
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Differentiation of hepatitis B virus genotypes D and E by ELISA using monoclonal antibodies to epitopes on the preS2-region product.
    Usuda S, Okamoto H, Tanaka T, Kidd-Ljunggren K, Holland PV, Miyakawa Y, Mayumi M.
    J Virol Methods; 2000 Jun; 87(1-2):81-9. PubMed ID: 10856755
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Targeted destruction of the polymerized human serum albumin binding site within the preS2 region of the HBV surface antigen while retaining full immunogenicity for this epitope.
    Park JH, Lee MK, Kim HS, Kim KL, Cho EW.
    J Viral Hepat; 2003 Jan; 10(1):70-9. PubMed ID: 12558915
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Presentation of two epitopes of the preS2 region of hepatitis B virus on live recombinant bacteria.
    Charbit A, Sobczak E, Michel ML, Molla A, Tiollais P, Hofnung M.
    J Immunol; 1987 Sep 01; 139(5):1658-64. PubMed ID: 2442253
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Screening a monoclonal antibody with a fusion-phage display library shows a discontinuity in a linear epitope within PreS1 of hepatitis B virus.
    Germaschewski V, Murray K.
    J Med Virol; 1995 Mar 01; 45(3):300-5. PubMed ID: 7539834
    [Abstract] [Full Text] [Related]

  • 15. In vitro neutralization of hepatitis B virus by monoclonal antibodies against the viral surface antigen.
    Ryu CJ, Gripon P, Park HR, Park SS, Kim YK, Guguen-Guillouzo C, Yoo OJ, Hong HJ.
    J Med Virol; 1997 Jun 01; 52(2):226-33. PubMed ID: 9179773
    [Abstract] [Full Text] [Related]

  • 16. An anti-preS2 antibody protects human hepatocytes from hepatitis B virus infection.
    Guo M, Kang B, Zheng Q, Qian Q, Su C, Wu M, Yang J.
    Acta Gastroenterol Belg; 2009 Jun 01; 72(3):306-11. PubMed ID: 19902863
    [Abstract] [Full Text] [Related]

  • 17. New broadly reactive neutralizing antibodies against hepatitis B virus surface antigen.
    Kucinskaite-Kodze I, Pleckaityte M, Bremer CM, Seiz PL, Zilnyte M, Bulavaite A, Mickiene G, Zvirblis G, Sasnauskas K, Glebe D, Zvirbliene A.
    Virus Res; 2016 Jan 04; 211():209-21. PubMed ID: 26541316
    [Abstract] [Full Text] [Related]

  • 18. Mutations in the envelope gene of hepatitis B virus variants co-occurring with antibody to surface antigen in sera from patients with chronic hepatitis B.
    Kohno H, Inoue T, Tsuda F, Okamoto H, Akahane Y.
    J Gen Virol; 1996 Aug 04; 77 ( Pt 8)():1825-31. PubMed ID: 8760433
    [Abstract] [Full Text] [Related]

  • 19. Synthetic oligopeptides bearing a common or subtypic determinant of hepatitis B surface antigen.
    Ohnuma H, Takai E, Machida A, Tsuda F, Okamoto H, Tanaka T, Naito M, Munekata E, Miki K, Miyakawa Y.
    J Immunol; 1990 Oct 01; 145(7):2265-71. PubMed ID: 1697880
    [Abstract] [Full Text] [Related]

  • 20. A monoclonal antibody specific to the non-epitope region of hepatitis B virus preS1 contributes to more effective HBV detection.
    Zhang Z, Li X, Yi W, Li S, Hu C, Chen A.
    Clin Biochem; 2013 Aug 01; 46(12):1105-1110. PubMed ID: 23608352
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.